NDC 50268-061

Acyclovir

Acyclovir

Acyclovir is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Avpak. The primary component is Acyclovir.

Product ID50268-061_64b811e9-81f5-4a37-e053-2a91aa0a319a
NDC50268-061
Product TypeHuman Prescription Drug
Proprietary NameAcyclovir
Generic NameAcyclovir
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-03-16
Marketing CategoryANDA / ANDA
Application NumberANDA075382
Labeler NameAvPAK
Substance NameACYCLOVIR
Active Ingredient Strength400 mg/1
Pharm ClassesDNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50268-061-15

50 BLISTER PACK in 1 BOTTLE, UNIT-DOSE (50268-061-15) > 1 TABLET in 1 BLISTER PACK (50268-061-11)
Marketing Start Date2011-03-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50268-061-11 [50268006111]

Acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA075382
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-03-16

NDC 50268-061-15 [50268006115]

Acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA075382
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-03-16

Drug Details

Active Ingredients

IngredientStrength
ACYCLOVIR400 mg/1

OpenFDA Data

SPL SET ID:6e203fa9-ee97-1e08-8d6a-fb57cfa13e19
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197311
  • 197313

    • Pharmacological Class

    • DNA Polymerase Inhibitors [MoA]
    • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • DNA Polymerase Inhibitors [MoA]
    • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Nucleoside Analog [EXT]

    Medicade Reported Pricing

    50268061915 OMEPRAZOLE DR 20 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    50268061911 OMEPRAZOLE DR 20 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    50268061813 OLANZAPINE ODT 20 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061811 OLANZAPINE ODT 20 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061713 OLANZAPINE ODT 15 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061711 OLANZAPINE ODT 15 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061613 OLANZAPINE ODT 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061611 OLANZAPINE ODT 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061513 OLANZAPINE ODT 5 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061511 OLANZAPINE ODT 5 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061415 OLANZAPINE 20 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061411 OLANZAPINE 20 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061315 OLANZAPINE 15 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061311 OLANZAPINE 15 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061213 OLANZAPINE 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061211 OLANZAPINE 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061115 OLANZAPINE 7.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061111 OLANZAPINE 7.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061015 OLANZAPINE 5 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061011 OLANZAPINE 5 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268006115 ACYCLOVIR 400 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268006111 ACYCLOVIR 400 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Acyclovir" or generic name "Acyclovir"

    NDCBrand NameGeneric Name
    0093-3630Acycloviracyclovir
    0093-8940AcyclovirAcyclovir
    0093-8943AcyclovirAcyclovir
    0093-8947AcyclovirAcyclovir
    0143-9657AcyclovirAcyclovir
    0143-9658AcyclovirAcyclovir
    0168-0825acycloviracyclovir
    0378-8700Acycloviracyclovir
    0378-8712AcyclovirAcyclovir
    0440-6030AcyclovirAcyclovir
    0440-7033acycloviracyclovir
    0472-0082AcyclovirAcyclovir
    0591-1159Acycloviracyclovir
    0713-0630AcyclovirAcyclovir
    0904-5789ACYCLOVIRACYCLOVIR
    0904-5790acycloviracyclovir
    10544-039Acycloviracyclovir
    10544-089Acycloviracyclovir
    10544-101AcyclovirAcyclovir
    68071-1841AcyclovirAcyclovir
    68071-3155AcyclovirAcyclovir
    68071-3222AcyclovirAcyclovir
    68071-4528AcyclovirAcyclovir
    68071-4559acycloviracyclovir
    68071-4345AcyclovirAcyclovir
    68084-109AcyclovirAcyclovir
    68084-108AcyclovirAcyclovir
    68071-4790AcyclovirAcyclovir
    68071-4799AcyclovirAcyclovir
    68084-107ACYCLOVIRACYCLOVIR
    68382-125acycloviracyclovir
    68382-049acycloviracyclovir
    68382-048acycloviracyclovir
    68382-668acycloviracyclovir
    68382-126acycloviracyclovir
    68382-792acycloviracyclovir
    68382-791acycloviracyclovir
    68382-992acycloviracyclovir
    68462-746acycloviracyclovir
    68788-6360acycloviracyclovir
    68788-0505AcyclovirAcyclovir
    68788-0504AcyclovirAcyclovir
    68788-0715AcyclovirAcyclovir
    68788-8989acycloviracyclovir
    68788-6827ACYCLOVIRACYCLOVIR
    68788-7382acycloviracyclovir
    68788-7378acycloviracyclovir
    68788-9783AcyclovirAcyclovir
    68788-7342AcyclovirAcyclovir
    68788-9690AcyclovirAcyclovir
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.